ArriVent BioPharma Overview
ArriVent BioPharma Discounted Cash Flow
DCF Analysis for AVBP.
Get informed when a big investor buys or sells
+ FollowFair Value
$1.18
Current Fair Value
$1.18
↓ 96.1% Downside
Overvalued by 96.1% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison